Literature DB >> 25985051

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation.

R Q Le1, X Tian2, N A Jain1, K Lu1, S Ito1, D A Draper1, P Anandi1, C S Hourigan1, N Dunavin1, A John Barrett1, M Battiwalla1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25985051      PMCID： PMC7438177          DOI： 10.1038/bmt.2015.112

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma.

Authors:  Luis F Porrata; Kay Ristow; Joseph P Colgan; Thomas M Habermann; Thomas E Witzig; David J Inwards; Stephen M Ansell; Ivana N Micallef; Patrick B Johnston; Grzegorz S Nowakowski; Carrie Thompson; Svetomir N Markovic
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

2.  Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.

Authors:  Andrew S Artz; Daniel A Pollyea; Masha Kocherginsky; Wendy Stock; Elizabeth Rich; Olatoyosi Odenike; Todd Zimmerman; Sonali Smith; Lucy Godley; Michael Thirman; Christopher Daugherty; Martine Extermann; Richard Larson; Koen van Besien
Journal:  Biol Blood Marrow Transplant       Date:  2006-09       Impact factor: 5.742

3.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

Review 4.  The EBMT risk score.

Authors:  A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2011-06-06       Impact factor: 5.483

5.  Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.

Authors:  T Lodewyck; M Oudshoorn; B van der Holt; E Petersen; E Spierings; P A von dem Borne; A Schattenberg; W Allebes; M Groenendijk-Sijnke; L Duinhouwer; R Willemze; B Lowenberg; L F Verdonck; E Meijer; J J Cornelissen
Journal:  Leukemia       Date:  2011-05-24       Impact factor: 11.528

6.  Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

Authors:  Robert Quan Le; J Joseph Melenhorst; Minoo Battiwalla; Brenna Hill; Sarfraz Memon; Bipin N Savani; Aarthi Shenoy; Nancy F Hensel; Eleftheria K Koklanaris; Keyvan Keyvanfar; Frances T Hakim; Daniel C Douek; A John Barrett
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

7.  Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant.

Authors:  Mary D Thoma; Tanya J Huneke; Lori J DeCook; Nicci D Johnson; Rob A Wiegand; Mark R Litzow; William J Hogan; Luis F Porrata; Shernan G Holtan
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-16       Impact factor: 5.742

8.  Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Robert Quan Le; Margaret Bevans; Bipin N Savani; Sandra A Mitchell; Kate Stringaris; Eleftheria Koklanaris; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-17       Impact factor: 5.742

9.  Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.

Authors:  Mohamed L Sorror; Barry Storer; Rainer F Storb
Journal:  Biol Blood Marrow Transplant       Date:  2009-04-11       Impact factor: 5.742

10.  Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation.

Authors:  Luis F Porrata; David J Inwards; Stephen M Ansell; Ivana N Micallef; Patrick B Johnston; William J Hogan; Svetomir N Markovic
Journal:  Bone Marrow Res       Date:  2013-04-28
View more
  3 in total

1.  Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation.

Authors:  Pere Barba; Ravin Ratan; Christina Cho; Izaskun Ceberio; Patrick Hilden; Sean M Devlin; Molly A Maloy; Juliet N Barker; Hugo Castro-Malaspina; Ann A Jakubowski; Guenther Koehne; Esperanza B Papadopoulos; Doris M Ponce; Craig Sauter; Roni Tamari; Marcel R M van den Brink; James W Young; Richard J O'Reilly; Sergio A Giralt; Miguel-Angel Perales
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-24       Impact factor: 5.742

Review 2.  Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis.

Authors:  Liangyou Gu; Hongzhao Li; Luyao Chen; Xin Ma; Xintao Li; Yu Gao; Yu Zhang; Yongpeng Xie; Xu Zhang
Journal:  Oncotarget       Date:  2016-05-31

3.  Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

Authors:  P Anandi; X Tian; F Chinian; C R Cantilena; N Dunavin; N Hensel; D Draper; E Koklanaris; S Maxwell; J Superata; P Muranski; M Battiwalla; S Paczesny; A J Barrett; S Ito
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.